Parents of teens and young adults should take five minutes to talk to their child’s healthcare provider about the five vaccine-preventable serogroups of meningitis and the two different types of vaccines needed to help protect against the disease.
- Meningococcal meningitis, often referred to as meningitis, is an inflammation of the protective membranes, or meninges, covering the brain and spinal cord.1
- About one in 10 people carry Neisseria meningitidis, the bacteria that can cause meningitis. These bacteria live in the back of the nose and throat. People who have the bacteria without any signs or symptoms of the disease are called “carriers”.2
- Early symptoms may be similar to those of a cold or the flu, but can progress quickly and can be fatal, or cause disability, sometimes within 24 hours.3,4 Symptoms can include fever, headache, and stiff neck as well as nausea, vomiting, sensitivity to light and confusion.4
Who should get vaccinated against meningitis?
According to the US Centers for Disease Control and Prevention:
- All 11 to 12 year olds should be vaccinated against serogroups A, C, W and Y with a booster dose given at 16 years old.6
- Teens and young adults aged 16 through 23 years may also be vaccinated against serogroup B, preferably at 16 through 18 years old.6
Talk to your teen or young adult’s healthcare provider about meningitis and the two different types of vaccines that together help protect against the five vaccine-preventable groups of the disease.
Learn more about meningitis and what you can do to help prevent it!
- Take 5 for Meningitis - filesize 86.4kb (PDF will open in new window)
- Knowledge Gaps in Vaccination Against Meningococcal Meningitis 326kb (PDF will open in new window)
- Vaccinate for Life
- The US Centers for Disease Control and Prevention
Disclaimer: External sites linked are not endorsed by GSK. We are not responsible for information that is provided on these sites.
1 CDC. Meningitis. Available at: https://www.cdc.gov/meningitis/index.html. Accessed July 2018.
2 CDC. Meningococcal Disease. Causes and Spread to Others. Available at: https://www.cdc.gov/meningococcal/about/causes-transmission.html/, Accessed July 2018.
3 CDC. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 8: Meningococcal Disease. Available at: https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html. Accessed July 2018.
4 CDC. Meningococcal Disease: Signs & Symptoms. Available at: https://www.cdc.gov/meningococcal/about/symptoms.html. Accessed July 2018.
5 CDC. Meningococcal Disease: Technical and Clinical Information. June 2016. Available at: http://www.cdc.gov/meningococcal/clinical-info.html. Accessed July 2018.
6 CDC. Meningococcal Vaccination: What Everyone Should Know. Available at https://www.cdc.gov/vaccines/vpd/mening/public/index.html. Accessed July 2018.
Find out more about us
Our vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across over 150 countries.
How we discover new vaccines
Our vaccines R&D is focused on discovering prophylactic and therapeutic vaccines to protect people against infectious diseases, cancers and chronic disorders.
Behind the science
Discover more about what we do, the people behind GSK and how we are working to help change the face of healthcare
Learn more about the flu and how you can help protect yourself and others from this potentially serious disease by getting vaccinated annually.